Evidence map›Paper›PMID 39430230›Full record

ArticleOne health (Amsterdam, Netherlands)2024

Pan-azole resistance in clinical

Hanne Debergh, Roel Haesendonck, Nadine Botteldoorn, An Martel, Frank Pasmans, Claude Saegerman, Ann Packeu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in One health (Amsterdam, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Global epidemiology of azole resistance inJAC-antimicrobial resistance · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hanne DeberghScientific Department Mycology and Aerobiology, Sciensano, 1050 Brussels, Belgium.
Roel HaesendonckZoolyx veterinary laboratory, Aalst, Belgium.
Nadine BotteldoornAnimal Health Care Flanders, Lier, Belgium.
An MartelUniversity of Ghent, Department of Pathobiology, Pharmacology and Zoological Medicine, 9820 Merelbeke, Belgium.
Frank PasmansUniversity of Ghent, Department of Pathobiology, Pharmacology and Zoological Medicine, 9820 Merelbeke, Belgium.
Claude SaegermanFundamental and Applied Research for Animal and Health (FARAH) Center, ULiège, 4000 Liège, Belgium.
Ann PackeuScientific Department Mycology and Aerobiology, Sciensano, 1050 Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aspergillosis causes significant health risks to both birds and mammals. The outcome of these infections is often poor due to delayed diagnosis and treatment failure. We investigated 152 cases of aspergillosis from birds and mammals in Belgium. Most samples originated from the taxonomic orders Artiodactyla (40.1 %) and Columbiformes (19.7 %). Five isolates (3.3 %) showed phenotypical resistance against at least one medical azole. Three of these isolates were pan-azole resistant bearing the TR34/L98H mutation. The predominance of this resistance mutation supports an environmental route for exposure and resistance selection, highlighting the importance of the One Health concept.

Identifiers

PMID39430230
PMCPMC11490837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.